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Downstream purification often represents the most cost-intensive step in the manufacturing of 
recombinant proteins. Conventional purification processes are lengthy, technically complicated, 
product specific and time-consuming. To address this issue, herein we develop a one step 
purification system that due to the nature of the non-selective secretion system and the versatility 
of ion-exchange membrane chromatography can be widely applied to the production of many 
recombinant proteins. This was achieved through the integration of the intrinsically coupled 
upstream, midstream and downstream processes, a connection that is rarely exploited.  
 A bioprocess for effective production and purification of penicillin G acylase (PAC) was 
developed. PAC was overexpressed in a genetically engineered Escherichia coli strain, secreted 
into the cultivation medium, harvested, and purified in a single step by anion-exchange 
chromatography. The cultivation medium developed had a sufficiently low conductivity to allow 
direct application of the extracellular fraction to the anion-exchange chromatography medium 
while providing all of the required nutrients for sustaining cell growth and PAC overexpression. 
It was contrived with the purposes of (i) providing sufficient osmolarity and buffering capacity, 
(ii) minimizing ionic species to facilitate the binding of extracellular proteins to anion-exchange 
medium, and (iii) enhancing PAC expression level and secretion efficiency. Employing this 
medium recipe the specific PAC activity reached a high level of 487 U/L/OD600, with more than 
90% was localized in the extracellular medium. Both, the osmotic pressure and induction 
conditions were found to be critical for optimal culture performance. Furthermore, formation of 
inclusion bodies associated with PAC overexpression tended to arrest cell growth, leading to 
potential cell lysis.  
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At harvest, the whole non-clarified culture broth was applied directly to a tangential flow 
filtration anion-exchange membrane chromatography system. One-step purification of 
recombinant PAC was achieved based on the dual nature of membrane chromatography (i.e. 
microfiltration-sized pores and anion-exchange chemistry). Due to their size, cells remained in 
the retentate while the extracellular medium penetrated the membrane. Most contaminate 
proteins were captured by the anion-exchange membrane, whereas the purified PAC was 
collected in the filtrate. The batch time for both cultivation and purification was less than 24 h 
and recombinant PAC with high purity (19 U/mg), process yield (74%), and productivity (41 
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Chapter 1 – Overview 
1.1 Research Background 
Recent advances in the fields of proteomics have lead to a greater understanding of proteins and 
their roles in disease and biochemical transformation, resulting in their ever increasing incorporation 
into a wide variety of industries including medical sciences and industrial manufacturing. Enzymes 
are employed in almost every industry; from polymerases and RNAses used in molecular biology 
labs to lipases and proteases used in laundry detergents. Reported in 2004, biopharmaceuticals 
accounted for an over 50 billion dollar market [1]. However, prior to any application, proteins must 
be manufactured in sufficient quantities with adequate purity and sensible cost. Due to extensive 
downstream purification required for the production of many proteins, cost remains one of the 
largest barriers to their wider implementation as therapeutics and biocatalysts. Downstream 
purification accounts for 40-75% of the total manufacturing costs of proteins depending on the 
subsequent applications [2, 3]. Conventional purification schemes are long tedious cascades with 
many steps. Every additional step, adds processing time, material, and equipment and decreases 
overall process yield. Thus innovations in protein purification, particularly versatile shortened 
simplified schemes, which reduce the cost of purification, would have far reaching effects in many 
industries. 
 A generic protein purification scheme generally follows the broad steps of clarification, 
capture, intermediate purification, polishing and formulation [3]. Whether a bioprocess includes all 
or some of these steps will depend on its end use. Biopharmaceuticals destined for human use 
require the highest purity and thus will include several purification steps and extensive polishing to 
remove toxins and viruses, while industrial enzymes often do not strictly require high purity and 
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thus may employ crude or partially purified cell extracts [2, 3]. Additionally, many common 
purification operations require preparatory steps such as buffer exchange or centrifugation which are 
not amenable to processing large volumes.  
 A recent shift in the paradigm of research methods in the scientific community has lead to an 
increased awareness regarding the importance of more integrated and systematic approaches to 
technical obstacles. A disconnect between the optimization of upstream, midstream and downstream 
elements exists in the field of bioprocessing and thus, an effective solution for decreasing the costs 
of downstream purification may be to integrate the development of the upstream/midstream with the 
downstream. However, exploitation of this intrinsic connection is uncommon as most recombinant 
proteins are produced intracellularly. Consequently, host/strain development and cultivation 
conditions have few effects on downstream operations which are mainly derived from the physical 
properties of the culture broth such as viscosity and colloidal content. Alternatively, processing of 
extracellularly secreted recombinant proteins would be highly affected by the composition of the 
cultivation medium and hold more promise for an integrated bioprocess. While extracellular 
production of recombinant proteins is often proposed as a possible strategy for facilitating 
downstream purification of proteins produced in Escherichia coli; due to the low level of host 
impurities found in this compartment, these bioprocesses have hitherto required tedious preparatory 
steps that may be just as costly as the additional purification steps required for an equivalent 
intracellular bioprocess. In conjunction with the low proteins titers often found in extracellular 
secretion systems in E. coli, the majority of recombinant proteins continue to be manufactured using 
intracellular methods [1].  
 Liquid chromatography is the most heavily relied upon technique for increasing protein 
purity. Conventionally, this employs a packed bed column which uses the inherent properties of the 
3 
 
protein to selectively separate it from other biomolecules. However, traditional columns have 
several well known limitations. When scaled to large volumes, slow binding kinetics dependent on 
intra-particle diffusion limits column operation to low flow rates, which translates to long down 
times for cleaning and regeneration, and causes large pressure drops, which necessitates expensive 
hardware [4-6]. Chromatographic membranes offer numerous advantages over traditional packed 
bed columns as convective transport of the materials to the ligands results in faster binding kinetics 
and as a result can be operated at much higher flow rates than packed columns [4, 5]. Additionally, 
they experience minimal pressure drop which decreases the equipment costs and hardware footprint. 
Membranes are easily manufactured on a large scale, and can be disposable, drastically decreasing 
down time and resulting in a faster overall bioprocess. Low binding capacity of commercially 
available membranes has prevented their wide spread implementation in applications other than 
flow through purification where the target concentration is low and the drawback of low binding 
capacity is outweighed by the benefits of increased productivity [5]. Recent improvements in 
membrane chemistry has resulted in more commercially available membrane adsorbers with binding 
capacities comparable to currently available resins creating a renewed interest in this technology. 
Furthermore, membranes can be manufactured in non-conventional filtration formats, potentially 
allowing processing of crude feed stocks that has thus far been the domain of expanded bed 
chromatography. 
 Accordingly, interfacing tangential flow filtration membrane chromatography with 
extracellular protein secretion using an integrated development approach can be used to create a fast 
and highly simplified E. coli recombinant protein expression and purification system that 
simultaneously clarifies and purifies recombinant protein. This rationale resulted in the development 
of a novel simplified bioprocess, which due to the non-selective nature of the extracellular secretion 
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system employed, and the versatility of ion-exchange membrane chromatography, can be widely 
applied for the production and purification of many recombinant proteins.  
1.2 Research Objectives 
The overall objectives of this thesis were to: 
1. develop an extracellular secretion system for the production of a suitable model protein 
(penicillin G acylase) with sufficient productivity to accurately study its purification;  
2. develop a cultivation medium with sufficiently low conductivity to allow subsequent protein 
binding to the ion-exchange membrane without any sample alterations;  
3. assess the binding behavior of chromatographic membranes in comparison to traditional 
columns and identify factors affecting membrane performance under the developed 
conditions; and 
4. develop a process scale application for tangential flow filtration ion-exchange membrane 
chromatography for the simultaneous clarification and purification of the extracellular 
recombinant PAC.  
1.3 Outline of Thesis 
A review of the current research in the extracellular secretion of recombinant proteins in E. coli, the 
uses and methods of purification for penicillin G acylase (PAC), the properties of chromatographic 
membranes and the current applications of membrane chromatography for the purification of 
proteins are presented in Chapter 2.  Chapter 3 presents the development of an extracellular 
secretion system for the purification of PAC and the brief optimization of the culture conditions 
which were devised with the purpose of facilitating protein binding to the ion-exchange stationary 
phase. Chapter 4 presents the development of a one-step purification scheme for the simultaneous 
5 
 
clarification and purification of PAC using tangential flow filtration anion-exchange membrane 
chromatography (TFF-AEMC).  Finally, Chapter 5 examines the potential applications of the 
developed bioprocess and areas requiring further investigation.   
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Chapter 2 – Literature Review  
Prior to the advent of recombinant DNA technology, proteins were undervalued due to their limited 
availability and the poor understanding of their roles in cellular processes. The fields of biochemical 
engineering and molecular biology have developed from an endeavor to address these issues and we 
are now capable of producing proteins on a sufficient scale for both the study of their function and 
for medical or industrial applications. In turn, increased understanding of the advantages of proteins 
in manufacturing applications and their role in disease has lead to their ever greater demand. Hence, 
proteins have and will continue to impact modern society profoundly.  
 While protein manufacturing methods are well established and high productivities are often 
possible, their adoption is often limited by their cost. Cost is mainly dictated by the downstream 
purification, which can account for 40-65% of the total manufacturing costs of industrial enzymes 
and may even be as high as 80% of the total manufacturing costs for highly purified therapeutic 
proteins [2]. Several well known approaches for the reduction of manufacturing costs include 
increasing protein titer through host engineering and/or optimization of cultivation to support high 
cell densities and the optimization of downstream operations to reduce process length, materials 
costs, and protein degradation.  
2.1 Expression Host 
Several expression systems for the recombinant production of proteins have been developed to meet 
the varying cellular processing needs of prokaryotic and eukaryotic proteins, and the industry’s need 
for more economical high level expression. As each system has its own advantages and 
disadvantages, the choice of host is often determined by the protein of interest itself as no one 
system is compatible with all proteins or all technical product requirements. The main 
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characteristics for the most popular bacterial expression system (E. coli) and common eukaryotic 
expression systems (yeast and mammalian) are summarized and compared in Table 2-1 [1, 7]. 
Despite of the limitations of bacterial hosts, E. coli remains one of the most commonly used 
expression hosts for the production of recombinant proteins due to the extensive knowledge of its 
genome, its amenability to genetic manipulation, its short generation time, its fastidiousness, and for 
its inexpensive cultivation requirements [1, 8, 9]. However, E. coli is often not a viable option for 
protein expression due to incompatible gene expression, protein misfolding, host/protein toxicity, 
formation of inclusion bodies, glycosylation, other posttranslational requirements, or regulatory 
concerns such as the presence of endotoxin [1, 7]. Regardless, the productivity of E. coli cultivation 
outstrips many of the other systems making it the most economical system and it continues to 
remain the workhorse of choice whenever possible.  
 
Table 2-1 - Comparison of common protein expression systems 
Characteristic E. coli Yeast Mammalian 
Growth Rate Fast Moderately Fast Slow 
Protein Productivity High  Moderately High Low 
Cost Low Low High 
Secretion Poor Moderate Good 
Inclusion Bodies* + + - 
Glycosylation* - + + 




as safe (GRAS) 
Human pathogens 









Scalability Easy and inexpensive Easy and inexpensive Difficult and costly 
* ‘+’ present, ‘-‘absent 
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2.2 Extracellular Secretion 
Very few proteins are naturally secreted in E. coli, and translocation into the extracellular space is 
complicated by the need to traverse two membrane barriers. Despite this, targeting of recombinant 
proteins to be secreted has long been a strategy for simplifying downstream recovery due to the low 
level of contamination of host cell proteins in the extracellular medium. Generally, targeting of 
extracellular proteins into the extracellular space in E. coli is a matter of weakening the outer 
membrane or using a transporter system [10-12]. Strategies that have been successfully employed 
include addition of extracellular transport signals [13], fusion with naturally secreted proteins such 
as hemolysin toxin [14], coexpression of release proteins such as the kil gene product or bacterial 
release protein [15, 16], use of outer membrane less L-form E. coli [17], use of outer membrane 
mutant strains [18, 19], and addition of chemicals that can permeabilize the cellular membranes 
such as glycine and Triton X-100 [20]. These strategies are summarized in Figure 2-1. Each of 
these strategies has their own drawbacks and one universally applicable high-level extracellular 
expression approach in E. coli has yet to be found. Some of the drawbacks include low level 
expression, non native protein structures, cell lysis, stress sensitivity, and growth impairment [10-
12]. Alternatively, extracellular secretion can also be employed as a strategy to improve production 
of difficult to express proteins. Expression in the extracellular or periplasmic space can often result 
in higher titers of soluble protein, possibly due to the larger presence of chaperone proteins and 
disulfide bond promoting proteins or from dilution into a compartment with lower protein 
concentration [11]. Additionally, secretion can provide increased protein stability of recombinant 




Figure 2-1 - Summary of extracellular secretion methods. Proteins are either directly transported 
through both membranes or first must be transported into the periplasm by transport machinery then 
released from the periplasmic space. (A) Outer membrane less L-form strains. (B) Mutations in 
major outer membrane components. (C) Permeabilization of the outer membrane through 
mechanical, chemical, or enzymatic treatments. (D) Specific extracellular transporters such as the 










 Approaches where recombinant proteins reach the extracellular medium through non-
specific periplasmic leakage have value as versatile secretion strategies. Many of these strategies do 
not involve extensive genetic alterations and may be highly influenced by the composition of the 
culture medium giving the operator greater control over protein expression [12, 21]. Leakage is 
achieved by increasing the permeability of the outer membrane through mechanical treatment 
(ultrasound), chemical treatment (EDTA, chelating agents, magnesium, calcium, glycine, and 
Trition X-100), enzymatic treatment (lysozyme), or by alterations in the host cell physiology 
through genetic means or adjustment of cultivation conditions [10, 11]. However, many of these 
methods are damaging to the host cells leaving them overly sensitive to their environment or 
causing significant cell lysis, as in the case of lysozyme treatment or ultrasound treatment 
respectively.  
 Recently, some success has been reported with the extracellular secretion of recombinant 
proteins by outer membrane mutant strains. The most extreme application of this is the use of L-
form strains which completely lack an outer membrane. While protein secretion is adequate in these 
strains, they are extremely sensitive to environmental conditions and cannot withstand the high 
shear stress experienced upon bioreactor cultivation making them unsuitable for industrial high-
density cultivation purposes [10, 17]. Less extreme cases of non-specific leaky strains employ cell 
envelope mutant strains with deletions or mutations in one or more outer membrane component 
such as lipoproteins (lpp), outer membrane proteins (ompF) or transporter machinery (tolA, tolB) 
[18, 22-24]. Particularly, murein lipoprotein deletion strains (Δlpp) show promise in the production 
of recombinant proteins as this deletion has been found not to significantly affect carbon 
metabolism or impair cell growth when compared to the parental strain [18, 19, 25-27]. 
Translocation into the extracellular compartment in these systems can be very high (>90% secretion 
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efficiency) with relatively little culture optimization and was found to be independent of cell lysis 
[18, 19, 26]. This method of extracellular secretion has been commercialized by Wacker Chemicals 
who now offer a patented modified outer membrane mutant strain and vector systems for the 
extracellular secretion of recombinant proteins in E. coli. However, it should be noted that strict 
cultivation conditions must be adhered to for high level secretion [28, 29]. 
 
2.3 Properties of proteins 
Development of a bioprocess starts with the determination of the criteria necessary for the product’s 
end use and an analysis of the composition of the purification feed stock. This includes criteria such 
as the purity, the quantity, the cost benefit, and any additional special requirements.  
Characterization of the feed; such as endotoxin, proteins, and nucleic acids, and determining which 
impurities within the stock are absolutely prohibited in the end product can greatly facilitate process 
design. With these criteria in mind, it is important to understand that proteins are biopolymers 
consisting of a non-random sequence of amino acids joined by peptide bonds. Accordingly, each is 
unique and differ in terms of molecular weight, electrostatic charge, solubility, and partitioning 
behavior, all of which can be exploited for their purification [2, 3, 30]. Additional characteristics 
such as fluorescence, catalysis or color while not useful for separations are often used for 
monitoring purification [2, 3, 30].  
2.4 Penicillin G Acylase 
Penicillin G acylase (PAC) was chosen as the model protein in this study as it is an industrially 
significant enzyme whose annual consumption was estimated at 10-30 million tons in 2008 and an 
enzymatic assay, which is both highly sensitive and accurate, is available [31, 32]. PAC catalyzes 
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the conversion of penicillin G or cephalosporin G and related antibiotics to 6-amino penicillanic 
acid (6-APA) or acetoxy cephalosporanic acid (7-ADCA), respectively, with phenyl acetic acid 
(PAA) as a byproduct [31, 33]. These precursors are then used to synthesize semi-synthetic β-lactam 
antibiotics. PAC from E. coli ATCC 11105 is a heterodimeric protein composed of a small ~25 kDa 
α-subunit and large ~65 kDa β-subunit which are formed through post-translational processing of a 
single polypeptide [15, 34, 35]. Many technical bottle necks occur in the production of this enzyme 
due to its unique protein formation pathway. PAC precursor protein is synthesized in the cytoplasm 
and must undergo translocation into the periplasmic space, periplasmic processing, and folding 
before becoming fully functional [34, 35]. Formation of inclusion bodies composed primarily of 
PAC precursor protein is a key obstacle upon the overexpression of the PAC operon and 
consequently, refolding is not possible and PAC must be manufactured in its soluble form [36]. 
Extracellular secretion has previously been proposed as a potential strategy for alleviating the 
metabolic pressure of PAC overexpression and increase the flux of soluble PAC. This strategy has 
seen some success via coexpression with the kil gene, which increased the amount of PAC produced 
three fold [15]. 
 Practically, PAC can be recovered after cellular disruption and isolation from the 
intracellular protein fraction or by first selectively extracting the periplasmic protein fraction 
through freeze-thaw, osmotic shock, enzymatic or other mechanical methods [37]. After 
clarification of the crude lysate, purification is generally achieved by selective ammonium sulphate 
precipitation followed by liquid chromatography [37, 38]. PAC has been successfully purified using 
almost all common chromatographic methods including ion-exchange, affinity, and hydrophobic 




2.5 Cultivation Conditions 
Cultivation conditions often play a significant role in the success of recombinant protein production 
and must be carefully optimized for each new protein product. Temperature, pH, osmotic pressure, 
medium composition (particularly carbon and nitrogen sources), and aeration can all have 
significant effects on growth rate, cellular physiology and gene expression [9, 42, 43]. Particularly, 
gene overexpression, oxygen limitation, nutrient limitation, and heat accumulation are all known to 
trigger cellular stress-responses which can cause growth impairment and increased protease activity 
[9, 44]. As E. coli is typically not sensitive to the shear stress experienced in a bioreactor, mixing 
and aeration are typically optimized to promote oxygen transfer and are balanced with the costs of 
power requirements. Cultivation temperature also dictates power requirements of a cultivation, and 
consequently because lower temperatures can increase productivity despite a decrease in growth 
rate, many industrial cultivations of E. coli are conducted below 30°C [8, 43]. 
Medium composition is crucial to achieving high cell density. Many nutrients must be 
controlled as they can inhibit growth at high concentrations, and as a result high cell densities can 
only be achieved through nutrient feeding during either fed-batch, chemostat or perfusion operations 
[8, 45]. Micronutrients such as magnesium and phosphate are essential and trace elements may be 
included to reduce the culture lag phase and increase protein yield [45]. While defined media are 
preferred for their reproducibility and higher degree of control, they are usually more expensive 
than complex or semi-defined media using complex components such as peptone or yeast extract 
[8]. Additionally, complex medium components have been known to increase protein yields and 
may promote soluble protein formation and therefore may be required to boost protein production at 
the expense of reproducibility [8].  
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2.6 Bioprocess Design 
Rational bioprocess design must first start with the characterization of the starting material 
including the target and its associated impurities. Following this, several criteria must then be 
defined to guide the development of the purification process based on the market need and end-use 
including: (i) how much protein is needed, (ii) how fast is it needed, and (iii) what purity is needed 
[2, 3]. The second criterion is of particular importance, not only due to the universal equation of 
          , but because proteins are subject to protease and denaturation at separation 
interfaces during purification [3]. Although, there is no universal bioseparation protocol that can be 
applied to every protein, generally purification is approached with the heuristic presented in Figure 
2-2 [2, 3]. Typically, the first step involves the separation of the cells from the cultivation medium. 
In the case of intracellular proteins, following concentration, cells are disrupted, cellular debris is 
removed via filtration or centrifugation, and the clarified lysate is subject to liquid chromatography 
for a primary capture step. Intracellular proteins will then be subject to multiple chromatographic 
steps depending on the level of purity required which is dictated by the protein’s end-use. Recovery 
is greatly simplified for extracellular proteins; after a solid/liquid separation step for the removal of 
cells and large debris the protein containing spent medium is concentrated using precipitation or 
another analogous technique followed by intermediate purification, due to the less complex nature 
of extracellular feed stocks. Following purification, therapeutic proteins require extensive polishing 
to remove viruses and endotoxin, while industrial enzymes may skip this step and proceed directly 
to formulation to preserve protein stability for product storage.  
While extracellular secretion has the potential to greatly reduce the costs of product 
recovery, it is not often employed in E. coli as the benefits of simplified purification are outweighed 
by the greater possible efficiency when processing feed stocks with higher protein titers. Regardless, 
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extracellular secretion may have the added benefits of not requiring the addition of stabilizers such 
as protease inhibitors due to the low level of cellular proteases present in the extracellular medium. 
Furthermore, it will not require enzymatic treatments such as treatment with DNAse, which is often 






















 Increasing attention is being paid to the benefits of integrated process design as 
complementary upstream, midstream, and downstream processes may improve process efficiency 
and yield. This principle was demonstrated for the production of human chymotrypsin B from P. 
pastoris [46, 47]. Cultivation conditions were selected to interface cultivation and purification in 
such as way as to directly transfer the product at the end of cultivation to the primary recovery 
operation with as little alterations to the spent medium composition as possible. The cell containing 
culture was processed directly using cation-exchange expanded bed adsorption (EBA) 
chromatography and compared to extraction of chymotrypsin B from the cell containing suspension 
using an aqueous two phase system (ATPS) [46, 47]. In the case of EBA, a single isolation step was 
sufficient for purification; however, this system requires large amounts of water and as the effluent 
contained recombinant organisms, the discharge required inactivation [47]. ATPS yielded similar 
protein purity as cation-exchange EBA; however, it required an additional operation for the 
recovery of the product from the poly(ethylene glycol) phase [47]. Regardless, Thommes et al. [47] 
elegantly demonstrated the intrinsic connection between cultivation conditions and purification and 
found that integrated process design was an effective solution for overcoming the difficult solid-
liquid separation step.  
2.7 Membrane chromatography 
Liquid chromatography is the most relied upon technique in protein purification. Traditionally, 
chromatography is conducted using functionalized cellulose based resins in tightly packed beds. 
Conventional columns have many well known limitations that make chromatographic operations 
expensive and time consuming. Thus, development of alternative stationary phases such as 
membranes, monoliths and mixed matrix membranes (resins embedded within a membrane 
support), and alternative techniques such as expanded bed chromatography, which may overcome 
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the limitations of packed-bed chromatography are of great interest to industry [48]. These 
limitations are partially a result of the slow intra-particle diffusion required for adequate binding in 
resin beads [4]. This imposes additional operational limitation such as slow flow rates, large 
pressure drops and long processing times [4, 5, 49]. Membrane adsorbers or chromatographic 
membranes offer a solution to these common technical problems as binding kinetics are independent 
of flow rate over a large range as transport of materials is dominated by convection [4, 5, 50]. A 
comparison of mass transport experienced in resin beads and membranes is illustrated in Figure 2-3 
[4]. Consequently, this allows membranes to operate under higher flow rates, with lower pressure 
drops, and may significantly shorten processing times [4, 5, 30, 49]. Additionally, membrane 
chromatography is directly scalable from lab to process scale reducing process development time.  
Several membrane geometries are available such as spiral wound devices or cross flow cassettes, 
and better large scale membrane manufacturing techniques are available making membranes less 
expensive than resins and potentially disposable, rendering regeneration and cleaning unnecessary 
















Membranes are now commercially available in all commonly applied chemical 
configurations including strong and weak cation and anion-exchange, immobilized metal affinity, 
protein A and G affinity, epoxy and aldehyde coupling affinity, and hydrophobic interactions [4, 5, 
49]. However, the majority of recent literature published on membrane chromatography continues to 
be focused on development of membrane chemistry to improve binding capacities, salt tolerance, 
and other physical properties of chromatographic membranes, and these studies model separation 
performance using single or binary mixtures of proteins, consequently, the amount of literature 
available on the separation of complex feed stocks is relatively poor compared to traditional 
columns [4, 51]. Due to low binding capacities, membrane adsorbers have found somewhat of a 
niche in the purification of large biomolecules (where binding of these molecules mainly takes place 
on the outer surface of the resin bead due to steric interference which impedes entry into the pores 
and severely reduces the resin’s binding capacity) and in flow-through polishing applications (such 
as the removal of virus and endotoxin in monoclonal antibody purification where the concentration 
of impurities is low) [51-55].  
A review of current ion-exchange membrane chromatography literature summarized in 
Table 2-2 shows that the majority of literature using ion-exchange membranes focuses on 
processing dilute feed stocks such as whey, plasma or culture supernatant. Affinity membranes are 
more commonly used for cell lysates [4]. This is likely due to three reasons, (i) the ability of ion-
exchange chromatography to bind and elute proteins in a more concentrated form, (ii) the high 
number of competing protein impurities for ion-exchange ligands in high protein content cell lysates 
necessitating high binding capacities for efficient purification, and (iii) the reduced level of 
competing impurities for the highly specific affinity ligands rendering the low binding capacities of 
affinity membranes acceptable. 
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Recently, an anion-exchange hollow fiber membrane was evaluated for its ability to separate 
common impurities in biopharmaceutical feed stocks such as DNA, host cell protein and viruses and 
found to be relatively more salt tolerant compared to the commercially available Mustang Q and 
Sartobind Q [56]. Cross-flow chromatographic membranes represent an advantage over traditional 
dead-end flow membranes devices as they allow simultaneous filtration and purification. However, 
examples of cross-flow operation of chromatographic membranes are rare and only a few studies 
chronicle the dynamic binding capacities of these membranes and the separation of complex media. 
Wolmann et al. [57] recently demonstrated the use of a hollow fiber membrane for the purification 
of lactoferrin from whey using immobilized Red HE 3B dye affinity chromatography. Their 
membrane had a dynamic binding capacity of 110 mg/mL of membrane volume and showed good 
separation ability. Whey processing could greatly benefit from membrane chromatography due to 
the dilute nature of the target and large sample volumes that must be processed. Accordingly, 
recovery of lactoferrin from whey and the separation of β-lactoglobulin and α-lactalbumin from 
whey have also been demonstrated using cross-flow mixed matrix ion-exchange membrane 
chromatography [58, 59]. Immobilized metal affinity hollow-fiber membranes have also been 
applied for the isolation of human IgGs from plasma with high purity (98%) and good resolution 
between different antibody subclasses and albumin [60].  
Major differences in the support and ligand chemistries of the chromatographic membranes 
presented in the literature make these membranes difficult to compare with each other and with 
traditional columns; however, many of the advantages list above have become well established 
knowledge and membrane adsorbers are becoming increasingly popular. The largest advantage is 
the potential for faster, more efficient processing and thus process economics is the driving force for 
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the application of these membranes and consequently, chromatographic membranes are finding their 
greatest advantage in polishing and single-use applications [6, 61].  
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Table 2-2 - Summary of ion-exchange membrane chromatography in the literature since 2005 







DEA & C 
 
4 mg/g for lysozyme n/d Amphoteric 
hollow fiber 
[62] 
Carbon nanofibres C 
 
>200 mg/g lysozyme SBC 
 






groups & CM  














C  122 mg/cm
3
 lysozyme >90%  Flat sheets [67] 
Polyethylene DEA 57 mg/mL BSA DBC 
~30mg/mL DNA DBC 
>5 LRV for PPV  
 
90% clearance of HCP in simulated 
CHO supernatant spiked with IgGs & 
PPV virus 
 
Hollow fibre [56] 
Polyethylene DEA-EA 
 
8.7 mg/mL gelsolin from bovine 
plasma DBC 
 
54% recovery of gelsolin from 
bovine plasma 




Q 57 mg/mL BSA DBC n/d Flat sheets [69] 
Polyethersulfone 
(Mustang) 
Q 16.1 mg/mL urease SBC 
12.4 mg/mL urease DBC 
2-6 mg/mL soybean  
proteins 
10-30 mg/mL corn proteins 
 
>80% recovery of urease from 
extracted soya or corn proteins 
spiked with urease 





S 22 mg/mL MAb1 5% DBC 
 
>90% recovery of MAbs, 70-80% 





Flat sheets [71] 
Polyethersulfone S n/d Separtion of BSA & hemoglobin 
mixture 
 
Dual layer hollow 
fiber 
[72] 
Polyimide  DEA 
 
n/d Separation of myoglobin & lysozyme 
mixture 
 
Flat sheets [73] 
Polypropylene Q (PMETAC) >80 mg/mL BSA SBC 
>120mg/mL trypsin inhibitor SBC 
 
>96% desorption for BSA Flat sheets [74] 
Polypropylene C (PAA)  56 mg/ SBC for lysozyme DBC 
 
 Flat sheets [75] 
Polypropylene DEA 120 mg/g BSA SBC 
102 mg/g BSA DBC 
 Flat sheets [76] 
Polysulfone S 140 mg/mL lysozyme SBC 
88 mg/mL ovalbumin SBC 
66 mg/mL conalbumin SBC 
 
 
95% recovery of lysozyme from egg 
white 
 
Hollow fibre [77] 
Regenerated Cellulose 
(Vivaspin) 
Q & S 11.4 mg/mL lysozyme for S 
15.8 mg/mL BSA for Q 
 
91% desorption of lysozyme for S 
74% desorption of BSA for Q 
Spin columns [78] 
Regenerated Cellulose 
(Vivaspin) 
Q & S HSA and IgG mixture 
Pencillin G acylase from E. coli 
lysate 
hGH from CHO cell culture 
supernatant 
 
100% purity for hGH from CHO 
cells 
57% recovery 
Spin column [79] 
Regenerated Cellulose 
(Vivaspin) 
Q  n/d 87.6% pure β-lactoglobulin from 
whey   
 
Spin column [80] 
Regenerated Cellulose 
(Sartobind) 
Q & S 1.02 mg/cm
2
 BSA for Q 
 0.91 mg/cm
2
 lysozyme for S 
92% desorption for BSA 
79% desorption for lysozyme 






Q & S  
 
n/d 93% recovery of human growth 
hormone (hGH) in CHO cell culture 
supernantant 
 





 for lactoferrin DBC >90% recovery of lactoferrin from 
whey 
95% purity for lactoferrin fractions 
85% purity for lactoperoxidase 
fractions 
 
Flat sheet [83] 
Regenerated Cellulose 
(Sartobind) 
S 11 mg/mL lysozme DBC 
24.6 mg/mL mono-PEG-lysozyme 
DBC 
 
n/d Flat sheets [84]  
Regenerated Cellulose 
(Sartobind) 
S n/d Separation of Mal d1 & Mal d2 
allergens 
 





55 mg/mL BSA SBC 
~25mg/mL BSA DBC 
100% desorption for BSA 
75% recovery of anthrax protective 
antigen from E. coli cell lysate with 
65% purity 
 





n/d >99% clearance of endotoxin 
 >98% recovery of Fibroblast growth 
factor 2 from E. coli cell lysate 
  
Flat sheets [87] 
Regenerated Cellulose 
(Sartorius Hydrosart) 
C : PAA 
C: crAA 
66 mg/mL IgG SBC for PAA 
89.5 mg/mL lysozyme SBC for 
crAA  
 
n/d Flat sheets [88] 
Regenerated Cellulose PDMAEMA 66.3 mg/mL BSA SBC 
47-49 mg/mL BSA DBC 
 
 Flat sheets [89, 
90] 
Regenerated Cellulose  PDMAEMA 130 mg/mL BSA DBC >98% recovery and >97% purity 
Hb/BSA solution 
 
Flat sheets [91] 
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Regenerated Cellulose  Q: PMETAC 
 
>130mg/mL IgG DBC  Flat sheets [92] 
Regenerated Cellulose  DEAE 135 mg/mL BSA SBC 
~80mg/mL BSA DBC 
 
65% recovery of APA, 85% purity Flat sheets [86] 
Regenerated Cellulose  DEAE  40 mg/g BSA SBC 
26.9 mg/g BSA DBC 
 
n/d Flat sheets [93] 
Regenerated Cellulose  C: PAA 98.5 mg/mL lysozyme SBC 
72.1 mg/mL lysozyme DBC 
 
n/d Flat sheets [94] 





Q: 2.9 mg/mL BSA DBC| 
AGM: 4.9 mg/mL BSA DBC 
TAEA: 4.2 mg/mL BSA DBC 
PHMB: 8 mg/mL BSA DBC  
PEI: 6.1 mg/mL BSA DBC  
 





Q n/d  > 4.5 LVR DNA 
 >  4.5 LVR endotoxin 
 > 5 LVR minute mouse viruses from 





Q n/d <  1 LVR DNA 





Q 67-73 mg/mL BSA DBC >  4.5 LVR DNA 
 > 7 LVR endotoxin 
 >3.5 LVR minute mouse viruses 
from clarified 324K cell lysate 
 [95] 
^ Q: Quaternary amine, S: Sulfonyl, C: Carboxyl, DEAE: Diethylaminoethyl, DEA: Diethylamine, EA: Ethanolamine, crAA: 
Poly(acrylic acid-co-methylene bisacrylamide), TAEA: Tris-2-aminoethyl amine, PHMB: Polyhexamethylene biguanide, AGM: 
Agamatine, PEI: Polyethyleneimine, PAA: Polyacrylamide, PMETAC: Poly(2-(methacryloyloxy)ethyl)trimethylamine), PDMAEMA: 
Poly (2-(dimethylamino)ethyl methacrylate), PSS: Polystyrene sulfonate 
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Bioprocess design for recombinant protein production is driven by the needs for high-level gene 
expression (developed in the upstream stage for strain design), large-scale production (conducted in 
the midstream stage for cultivation), and acceptable protein quality (addressed in the downstream 
stage for purification). Typically, downstream purification represents the most significant expense 
in protein manufacturing by accounting for 40-65% of the total manufacturing cost [2, 3]. 
Technological experience accumulated over the past few decades has highlighted the importance of 
more systematic and integrated approaches for bioprocess development. As a result, tackling 
technical issues in the upstream and/or midstream stages might be an effective solution to the 
reduction of the high cost associated with the downstream processing stage. However, such an 
intrinsic connection among all bioprocessing stages is rarely exploited. Hence, the focus of this 
study is to use this integrated approach to demonstrate a novel bioprocessing application for 
recombinant protein production, whereby recombinant protein was produced extracellularly under 
cultivation conditions that allow direct protein capture and single step purification from the cell-free 
medium.   
E. coli secrets few proteins extracellularly and, consequently, targeting of recombinant proteins 
into the extracellular compartment becomes difficult and is better achieved in Gram-positive 
species, which lack the outer membrane, or yeasts, which are better equipped for excretion [43]. 
However, the lack of native protein secretion in E. coli makes the extracellular production of 
recombinant proteins using this common host system highly desirable as a method of simplifying 
downstream processing. By targeting recombinant proteins into the extracellular compartment, the 
level of contaminant proteins from the host cells can be significantly reduced and the foreign gene 
products are sequestered away from intracellular proteases [10, 11]. Strategies for protein secretion 
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in E. coli have been extensively reviewed and generally involve either weakening the cellular 
envelope or using a transporter system [9-11, 28]. Practical approaches that have been explored 
include the addition of extracellular transport signals, fusion with naturally secreted proteins such as 
hemolysin toxin [14], coexpression of release proteins [15], use of L-form E. coli [17], and addition 
of chemicals that can cause cellular permeation [20]. Each of these approaches has individual 
drawbacks, such as low productivity, non-native protein structure, cell lysis, stress sensitivity, and 
growth arrest [11, 43]. Strains with mutation(s) in the major outer membrane components were 
identified as potential platforms for secretion of periplasmic proteins into the extracellular medium 
[10, 11]. However, they were not thoroughly investigated as it was generally believed that these 
strains were growth-impaired and cannot be cultured to a high cell density for industrial 
applications. Recently, interest in these strains has been renewed by partially overcoming the 
growth issue. For example, knocking out the lpp gene encoding murein lipoprotein allows the 
secretion of recombinant proteins targeted in the periplasm into the extracellular medium without 
severely retarding cell growth [18, 19]. Furthermore, the use of outer membrane mutants as 
expression hosts could potentially enhance recombinant protein production due to the increased 
solubility of proteins in the periplasm and could potentially be combined with other genetic 
strategies such as coexpression of periplasmic chaperones and knock-out of periplasmic proteases 
[10, 11].  
In this study, using penicillin G acylase (PAC) as the target protein, an Escherichia coli 
host/vector system was developed for high-level expression and extracellular secretion of 
recombinant PAC. A cultivation medium was specifically developed to enhance culture 
performance and facilitate harvest and purification of secreted recombinant PAC directly from 
unaltered cell-free medium by anion-exchange chromatography. PAC was selected as a target 
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protein due to its industrial significance in the production of β-lactam antibiotics [31]. It is a 
heterodimeric protein maturing through posttranslational modification in the periplasm of E. coli 
[15, 96]. PAC precursors tend to misfold and form inclusion bodies upon the overexpression of the 
pac gene in E. coli and this has been identified as one of the major limitations on the production of 
this industrial enzyme [96]. Practically, PAC is purified primarily through chromatographic 
techniques, including anion-exchange chromatography, cation-exchange chromatography, and even 
affinity chromatography [38-40]. Due to the nature of the intracellular production of PAC, these 
chromatographic techniques often represent a major purification effort after a tedious multi-step 
pretreatment, including cell harvest, cell disruption, protein precipitation, and desalting [38].  
The extracellular production of PAC developed in this study offers an attractive scheme to 
significantly reduce bioprocessing complexity and operating cost. Downstream purification of PAC 
was facilitated by direct loading of cell-free medium for one-step anion-exchange chromatography. 
While it is not uncommon for extracellular proteins to be purified using anion-exchange 
chromatography, the spent medium is subject to various pretreatments, such as centrifugation, 
ultrafiltration, dialysis, and precipitation for the removal of excess salts and large debris prior to its 
application. Typical media for high-cell-density cultivation of E. coli contain a relatively high 
concentration of salts and/or various complex and charged components, such as oligopeptides, 
which may complicate the operation of anion-exchange chromatography [8]. Hence, a major 
challenge for direct capture and purification of PAC from the spent medium is to develop an 




3.2 Materials and Methods 
3.2.1 Bacterial strains and plasmids 
JE5505 (F
-
, Δ(gpt-proA)62, lacY1, tsx- 29, glnV44(AS), galK2(Oc), & λ-, Δlpp-254, pps-
6,hisG4(Oc), xylA5, mtl-1, argE3(Oc), thi-1) [97], HB101 (F
-
, hsdS20, leuB6, recA13, ara-14, 
proA2, lacY1, thi-1, galK2, rpsL20, xyl-5, mtl-1, supE44, λ
-







 lacZΔM15], recA1, supE44, endA1, hsdR17, gyrA96, relA1, thi-1, mcrA, Δ[lac-proAB]) 
obtained from the CCRC, Taiwan were used as the hosts for the production of recombinant PAC. 
The plasmid pTrcKnPAC2902 containing the pac operon from E. coli ATCC11105 regulated by the 
trc promoter was previously constructed [96]. 
3.2.2 Cultivation  
The recombinant strain was stored at -80°C as an LB/glycerol stock. The cells were revived by 
streaking on LB agar plates with kanamycin (50 μg/mL). A single colony was inoculated into a 
flask with 50 mL of LB medium (5 g/L yeast extract, 10 g/L tryptone, 0.5 g/L NaCl, and 50 μg/mL 
kanamycin) and incubated at 30°C  in a rotary shaker for 16 h at 200 rpm. Fifty milliliters of this 
seed culture (2%) was used to inoculate a bench-top bioreactor (Omni-Culture, VirTis, Gardiner, 
NY) containing 1 L working volume of medium with 20 μL/L Antifoam 204 at 28°C (Sigma, St. 
Louis,MO). Various media were prepared with composition listed in Table 3-1. Chemicals such as 
yeast extract, Tryptone, and casamino acids were purchased from BD (Franklin Lakes, NJ, USA), 
while chemicals such as 3-(N-morphlino)propanesulfonic acid (MOPS) and NaCl were purchased 
from Fisher Scientific (Waltman, MA, USA). Trace elements were added to a final concentration of 
2 mM MgSO4∙7H2O, 2 mM KH2PO4, 0.2 mM CaCl2∙2H2O, 1.5 mg/L of FeSO4∙7H2O and 0.6 mg/L 
of ZnSO4∙7H2O, MnSO4∙7H2O, CuSO4∙7H2O, and 3 mg/mL thiamine where indicated. Protein 
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expression was induced with the indicated concentration of isopropyl β-D-thiogalactopyranoside 
(IPTG) when the cell density reached approximately 0.5 OD600. The bioreactor was purged with 
filter-sterilized air and agitated at the rates given in Table 3-1. The pH was regulated at 7.0 ± 0.1 by 
the addition of 1 N NH4OH or 1 N HCl using a combination pH electrode (Mettler-Toledo, 
Switzerland), a pH controller (PC310, Suntex, Taipei, Taiwan), and two MasterFlex peristaltic 
pumps (Cole-Palmer,Vernon Hills, IL, USA). 
3.2.3 Treatment of culture sample 
The culture sample was appropriately diluted with 15 mM NaCl for measuring cell density at 600 
nm with a spectrophotometer (DU520, Beckman Coulter, Fullerton, CA, USA). For the preparation 
of the cell extracts, 20 OD units were centrifuged at 2°C and 6000 g for 6 min in a Hettich Universal 
320 R centrifuge (Hettich Instruments, Beverly, MA, USA). The supernatant containing 
extracellular proteins was analyzed for secreted PAC. The cell pellet was resuspended in 1 mL PBS 
(0.05 M, pH 7.4) and sonicated for 5 min using an ultrasonic processor (Misonix, Farmingdale, NY, 
USA). The cell lysate was centrifuged at 2°C for 10 min at 10000 g. The supernatant was analyzed 
for soluble intracellular PAC activity. The pellet containing insoluble proteins was resuspended in 
TE/SDS buffer (10 mM Tris HCl pH 8, 1 mM EDTA, 1% SDS) and heated at 95°C for 5 min. All 
fractions were analyzed by SDS-PAGE and western blotting. 
3.2.4 Enzyme assay 
Penicillin G acylase was assayed at 37°C using penicillin G as a substrate. The amount of enzymatic 
reaction product, 6-aminopenicillanic acid (6-APA), was quantified using a colorimetric method 
developed previously [32]. All assays were conducted in duplicate. One unit was defined as the 
amount of enzyme that hydrolyzed 1.0 μmol penicillin G per minute at 37°C. The specific activity 
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(in U/L/OD600) was calculated as the quotient of the activity (in U/L) and cell density (in OD600). 
The secretion efficiency (%) was determined as the fraction of total PAC activity that was 
extracellular.   
3.2.5 Total protein assay 
The bicinchoninic acid assay (BCA) for total protein concentration was performed using a kit 
(Pierce Biotechnology, Rockford, IL, USA) in the microplate assay format. Samples were all 
performed in duplicate and were appropriately diluted in 25 mM Tris-HCl (pH 8) to fall in the linear 
range of the kit. The standard curve was performed in duplicate for each plate with bovine serum 
albumin. Absorbance was measured at 562 nm with a Thermo Labsystems Multiskan Ascent 
photometric plate reader (Thermo Scientific, Wilmington, USA). 
3.2.6 SDS-PAGE and Western blot  
Sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) was performed in a Mini-
PROTEAN II electrophoresis cell (Bio-Rad, Hercules, CA, USA) using a 12.5% polyacrylamide 
separating gel stacked by a 4% polyacrylamide stacking gel. Final loading amount for total protein 
(soluble and insoluble) was 0.1 OD600 units, while 10 μL was loaded for extracellular supernatant 
and for chromatography fractions. Electrophoresis was conducted under a constant voltage of 200 V 
for 60 min. Gels were either stained using silver nitrate and dried, or used for western blot analysis. 
For western blots, gels were electroblotted on to a PVDF membrane (Pall Corporation, Port 
Washington, NY, USA) using a Mini Trans-Blot Cell (BioRad, Hercules, CA, USA) according to a 
standard protocol [99]. The electrophoretic transfer was conducted at a constant voltage of 100 V 
for 1 h. Protein-antibody hybridization was performed as described by the membrane manufacturer 
[100]. The primary antibody was a polyclonal rabbit anti-PAC β-subunit IgG and the secondary 
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antibody was a goat anti-rabbit IgG conjugated with horseradish peroxidase (HRP) (Sigma, St. 
Louis, MO, USA). HRP was detected by colorimetric visualization using 3-3-diaminobenzidine 
tetrahydrochloride (DAB) as the substrate. Dried SDS-PAGE gels and western blots were scanned 
using an HP laserjet scanner 3020.  
3.2.7 Anion-exchange chromatography 
Anion-exchange chromatography was performed using a low pressure liquid chromatography 
system (Bio-Logic LP, Biorad, Hercules, CA) which allowed online UV absorbance (280 nm) and 
conductivity monitoring using the accompanying software (LP Logic, Biorad, Hercules, CA). A 
5mL Q Sepharose™ Fast Flow Column (GE Healthcare, Buckinghamshire, UK), herein refered to 
as QFF columns, with a reported dynamic binding capacity of 120 mg of HSA per milliliter of resin 
was attached upstream of the indicators and downstream of the sample loading device. The column 
was equilibrated for 15 min at the indicated flow rate (either 1 mL/min or 4 mL/min) with the 
appropriate loading buffer (either 25mM Bis-Tris-HCl pH 7 or 25mM Tris-HCl pH 8). Samples of 
2.5, 30, 50, 60, 300 mL of culture broth were harvested from cultivation of JE5505 harboring 
pTrcKnPAC2902 in LCM3 medium after 12 h of induction with 0.15 mM IPTG. The samples were 
centrifuged at 6000 g for 10 min and filtered with 0.22 μm polyethersulfone syringe filters (VWR, 
Radnor, PA, USA) to remove cell debris. These samples were either directly loaded at their current 
pH of 7 or adjusted to a pH of 8 by addition of 3 N NaOH before loading. After loading, weakly 
bound protein was removed from the column by washing with loading buffer for 10 min at the 
indicated flow-rate. Following the washing step, either a 60 mL linear salt gradient from 0-1 M 
NaCl was used to elute proteins from the column or a step-wise elution using 10 mL of 1 M NaCl 
was performed as indicated by the chromatogram conductivity. All steps were performed at the 
same  flow-rate. Eight milliliter fractions were collected with a fraction collector (BioLogic 
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BioFrac, Biorad, Hercules, CA) and pooled into loading flow-through, wash flow-through, and 
elution peaks. All fractions were assayed using the BCA and PAC enzyme assay and analyzed using 
SDS-PAGE. Pooled fractions were desalted by diafiltration over 25 fold to remove oligopeptides 
using 3 kDa cut-off ultrafiltration centrifugal devices (Palls Corporation, St.Louis, MO, USA). 
Chromatography was performed in duplicate under identical chromatography conditions with broth 
from different cultivations. 
3.3 Results and Discussion 
3.3.1 Extracellular PAC expression by leaky outer-membrane mutant 
Industrial bioprocesses require strains which can attain a high cell density with a relatively 
high growth rate and are less sensitive to harsh bioreactor environment. To determine whether the 
lpp-deletion mutant, JE5505, would be a suitable strain for extracellular PAC production, the 
plasmid pTrcKnPAC2902 was transformed into this strain. HB101 with an uncompromised outer 
membrane was used as a control strain for comparison. Initially, cultivation of JE5505 harboring 
pTrcKnPAC2902 in LB medium induced with 0.1 mM IPTG was performed to verify its capacity in 
the extracellular production of PAC under bioreactor conditions (Table 3-1). The specific PAC 
activity in the extracellular fraction was significantly higher than that exhibited by the control strain 
HB101 harboring pTrcKnPAC2902 (40% vs. 11%) under similar culture conditions. It should be 
noted that a low level extracellular secretion is expected for the control strain due to the natural 
leakage of periplasmic proteins during growth [11]. However, due to its high oligopeptide content, 
LB was not compatible with the subsequent step of anion-exchange chromatography. The sample 
medium loaded for ion-exchange chromatography must also have a low ionic strength to allow 
proper binding of proteins to the chromatographic matrix. Additionally, the extracellular production 
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of PAC from cultivation in LB was limited by the low final cell density. Therefore, more than 
twelve medium recipes were formulated for cultivation under different bioreactor conditions and the 
culture performance of four distinct media is summarized in Table 3-1. For most cultivations, the 
PAC expression level and secretion efficiency increased with cultivation time and reached a plateau 




Table 3-1 - Summary of culture performance for extracellular production of penicillin G acylase in 
various media formulated for subsequent ion-exchange chromatography 
Strain  JE5505 HB101 
Medium Name LB LCM1 LCM2 LCM3 LCM3 LCM3 
Medium Composition 
   
 
  
Glucose [g/L] - 6 6 6 6 6 
NaCl [g/L] 10 0.1 0.1 0.1 0.1 0.1 
Casamino acids [g/L] - 2.5 2.5 5 5 5 
Yeast extract [g/L] 5 - - 2.5 2.5 2.5 
Tryptone [g/L] 10 - - - - - 
MOPS buffer [mM] - - 20 20 20 20 
Trace element solution* - + + + + + 
Cultivation Conditions 
   
 
  
Agitation [rpm] 250 500 250 250 250 250 
Aeration [vvm] 1 2 1 2 2 2 
IPTG induction [mM] 0.1 0.05 0.1 0.1 0.15 0.15 
Culture Performance 
   
 
  
Cell density [OD600] 1.3 1.6^ 1.6 1.9 2.6 5.1 
Conductivity [mS/cm] >30 4.7 4.4 6.7 6.8 6.6 
Extracellular PAC activity 
[U/L/OD600] 
206 58 85 199 442 128 
Total PAC activity 
[U/L/OD600] 
512 102 88 206 487 556 
Secretion efficiency 40% 57% 96% 97% 91% 23% 
* + indicates addition of trace element solution describes in materials and methods 
^ Growth rate of this culture was severely impaired due to increased sensitivity of JE5505 to 




3.3.2 Formulation of medium with a low ionic strength  
Typically, the ionic strength permissible for ion-exchange chromatography operation should 
be less than 5-7 mS/cm [101]. Common complex medium components, such as yeast extract, 
contain oligopeptides that can interfere with protein binding for ion-exchange chromatography. 
Consequently, a defined medium using low conductivity components was developed not only to 
reduce the ionic strength and the oligopeptide content, but also to sustain simultaneous cell growth 
and high-level production of extracellular PAC. Several medium components for E. coli cultivation 
[102] were screened using shaker-flask cultivation by evaluating cell growth and the conductivity of 
spent medium. A medium recipe consisting of mainly glucose, casamino acids, and a minimal 
amount of salts was formulated. This medium had a conductivity of 3.3 mS/cm before cultivation 
and a final conductivity of less than 5 mS/cm after cultivation. The increase in the ionic strength 
during cultivation was associated with the addition of base for pH control. The growth of JE5505 
harboring pTrcKnPAC2902 in LCM1 was severely impaired in the bioreactor. Surprisingly, the 
growth of one of the control strain, JM109 harboring pTrcKnPAC2902 in LCM1 medium, was not 
retarded under a similar bioreactor condition (reached a density of 3.3 OD600 within 4 h post-
induction). It was further observed that the cell growth of JE5505 harboring pTrcKnPAC2902 was 
not improved by decreasing the agitation speed in the bioreactor, but such growth retardation no 
longer existed when cultivating in shaker flasks (reached a density of 0.8 OD600 within 6 h of 
inoculation). Based on these observations, it was postulated that the host strain of JE5505 could be 
particularly sensitive to shear stress under low osmolarity conditions due to its destabilized outer 
membrane. In fact, it was previously reported that JE5505 had a decreased growth rate in low ionic-





 ions from the medium [21, 103]. Consequently, the medium (named 
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LCM2) was altered to include MOPS, which has a low conductivity and can provide a buffering 
capacity at pH 7 during cultivation. As a result, the amount of ions added for pH control during the 
cultivation was significantly reduced and the unaltered spent medium could be directly loaded for 
anion-exchange chromatography [104]. The application of LCM2 could alleviate the growth 
impairment of JE5505 harboring pTrcKnPAC2902 in the bioreactor while maintaining a low 
conductivity and suitable pH of the spent medium. Most importantly, the level of the extracellular 
secreted PAC increased to 96%, although the specific and total PAC activity remained relatively 
low. Alternatively, M9 medium supplemented with 1% casamino acids and 1% glucose could be 
used to achieve high secretion efficiency. It has been shown that 95% secretion efficiency was 
obtained upon expressing recombinant human secretory pancreatic trypsin inhibitor protein [26]. A 
similar M9 medium was also successfully applied to achieve over 90% secretion efficiency upon the 
expression of recombinant xylanase and cellulase using another lpp deletion strain of C609Y [18]. 
However, the relatively high salt concentrations in the M9 medium precluded its application in the 
current study.  
3.3.3 Effect of medium composition on the production of PAC 
It was reported that the inclusion of complex medium components during cultivation may 
enhance recombinant protein production [8, 105]. Thus, the effects of complex medium components 
(specifically, yeast extract and casamino acids) and induction conditions on the production of PAC 
were investigated. JE5505 harboring pTrcKnPAC2902 was cultivated in LCM3 medium and the 
production of PAC was induced by 0.1 mM IPTG. This resulted in an increased total PAC activity 
with an increased final cell density, unaltered secretion efficiency, and a permissible conductivity of 
the spent medium. The increased supplementation of amino acids could potentially decrease 
protease activity induced by a stringent-like stress response [44] associated with amino acid 
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limitation, resulting in a reduced degradation of PAC. In addition, the supplementation of non-
essential nutrients such as vitamins and nucleotides in the complex medium components may be 
critical for enhancing the production of PAC. While complex medium components are generally not 
preferred for large scale cultivations, the supplementation of yeast extract appears to be critical for 
effective extracellular production of PAC. The total specific PAC activity was further increased 
without any adverse effect on cell growth and PAC secretion efficiency when the IPTG 
concentration was increased to 0.15 mM, implying the importance of determining an appropriate 
induction condition for optimal culture performance.  
3.3.4 Effect of inclusion body formation 
The culture performance of both JE5505 harboring pTrcKnPAC2902 and HB101 harboring 
pTrcKnPAC2902 using LCM3 medium is summarized in Figure 3-1 and 3-2, respectively. The 
production of PAC by JE5505 harboring pTrcKnPAC2902 was primarily formed during the growth 
phase as more than 90% of the total recombinant PAC was synthesized within the first 8 h of 
induction with an effective extracellular secretion. After this production period, cell growth was 
arrested and then the culture pH became basic, suggesting possible depletion of glucose [106]. 
Although the recombinant host strain of JE5505 exhibited poor growth in this study (1 OD600 = ~0.5 
g/L dry cell weight [107]), it was previously shown to reach a high cell density of 26 g/L dry cell 
weight using fedbatch cultivation for the production of interferon [108]. Nevertheless, a low ionic 
strength might not be easily maintained in a fedbatch culture, due to the addition of acid and base 
for pH control. In that regard, chemostat cultivation could be an alternative approach for this type of 
operation due to the dilution effect of the continuous feed. On the other hand, HB101 harboring 
pTrcKnPAC2902 had more prolonged cell growth than JE5505 harboring pTrcKnPAC2902 with 
approximately the same pac gene expression level under identical bioreactor conditions, possibly 
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due to a healthier cell physiology. The improved cell growth resulted in an increased volumetric 
PAC activity. Note that, compared to the traditional approach for intracellular production of PAC, 
the secretion strategy adopted in this study appears to hardly affect the pac gene expression level. 
The insoluble fraction of cell lysate was also analyzed by Western blotting (Figure 3-1B and 3-2B). 
It was rather surprising that a significant amount of inclusion bodies composed of PAC precursors 
accumulated in JE5505 harboring pTrcKnPAC2902, but not HB101 harboring pTrcKnPAC2902; 
and this might potentially result in the difference in cell physiology. HB101 harboring 
pTrcKnPAC2902 was previously reported to form inclusion bodies when cultivated in LB medium 
under similar cultivating conditions [96]. These previous and current results suggest that both host 











           
Figure 3-1 - Culture performance for the production of PAC using JE5505 harboring 
pTrcKnPAC2902 in LCM3 medium induced with 0.15 mM IPTG in a bioreactor. (A) Time profile 
showing the cell density (diamond), specific intracellular PAC activity (triangle) and extracellular 
PAC activity (square).  (B) Immunological analysis showing the localization of PAC. Samples of 
the extracellular, intracellular soluble protein and intracellular insoluble protein fractions taken at 
different time points from 0-24 h after induction were analyzed. PAC precursor and mature PAC 





Figure 3-2 - Culture performance for the production of PAC using HB101 harboring 
pTrcKnPAC2902 in LCM3 medium induced with 0.15 mM IPTG in a bioreactor. (A) Time profile 
showing the cell density (diamond), specific intracellular PAC activity (triangle) and extracellular 
PAC activity (square).  (B) Immunological analysis showing the localization of PAC. Samples of 
the extracellular, intracellular soluble protein and intracellular insoluble protein fractions taken at 
different time points from 0-24 h after induction were analyzed. PAC precursor and mature PAC 




Several effects were identified to be associated with the formation of inclusion bodies upon 
the pac gene overexpression in E. coli, including the toxicity of inclusion bodies (deteriorating cell 
physiology), misfolding of PAC precursors in the cytoplasm and/or periplasm, and ineffective 
posttranslational processing (i.e. autoproteolysis) of PAC precursors in the periplasm [15, 36, 96, 
109]. Extracellular secretion of intracellular proteins was proposed to have the potential to alleviate 
inclusion body formation due to the release and dilution of the accumulated proteins inside cells [10, 
15]. Such general knowledge for extracellular protein release was apparently in contradiction to the 
current results, i.e. effective expression/secretion of PAC accompanied significant inclusion body 
formation (in JE5505 harboring pTrcKnPAC2902) whereas intracellular overexpression of PAC 
resulted in hardly any inclusion body formation (in HB101 harboring pTrcKnPAC2902). While 
medium composition was proposed to be a potential factor, poor cell physiology associated with the 
leaky nature of JE5505 could be critical for inclusion body formation. The characterization of such 
an effect will improve the understanding of the formation mechanism of PAC inclusion bodies.  
3.3.5 Downstream purification of PAC  
Based on the isoelectric point of PAC (pI ~ 6) [110], anion-exchange chromatography was 
used as a major purification step for the downstream processing of PAC. The low ionic strength of 
the clarified spent LCM3 medium containing extracellularly secreted PAC produced by JE5505 
harboring pTrcKnPAC2902 allowed its direct loading onto the chromatographic column. The 
purification results are summarized in Figure 3-3. While the purification performance under the two 
pH values investigated was rather indistinguishable, the operation under pH 8 had a higher peak 
resolution possibly due to the decreased volumetric flow rate used in that experiment. PAC was 
harvested and purified through a “negative” separation scheme since, according to the SDS-PAGE 
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analysis, PAC was the major species present in the flow-through fraction and the majority of the 
contaminant proteins were adsorbed onto the chromatographic column and then eluted in the 
fractions corresponding to the first or second peak. Only 2.5% of the total PAC activity loaded to 
the column was detected in the washing flow-through and elution fractions. The fractions 
corresponding to the last peak eluted at a high salt concentration were primarily composed of RNAs 
(Figure 3-4) due to a low level of cell lysis during the cultivation. A pH value of 7.0 was however 
selected as the operating pH to minimize the pH fluctuation during the chromatographic operation 
as the cultivation was also conducted under this pH. A relatively high flow rate of 4 mL/min was 
used to facilitate the chromatographic operation given that the resolution associated with the elution 
step is not critical for a “negative” separation. Purification of PAC under these operating conditions 
is summarized in Table 3-2. While the purified PAC was still contaminated by oligopeptides which 
were not removed during the chromatographic operation, the purity was justified to be high enough 























Figure 3-3 - (A) Chromatogram when 50 mL of spent LCM3 medium from the cultivation of 
JE5505 (pTrcKnPAC2902) adjusted to pH 8 was loaded to a 5 mL QFF anion-exchange column at a 
flow rate of 1 mL/min. UV absorbance is indicated with a solid line and conductivity is indicated 
with a dashed line. Major steps are indicated above the plot including: loading flow-through (L), 
washing flow-through (W), elution 1 (E1), elution 2 (E2), and elution 3 (E3) if applicable.  (B) 
SDS-PAGE analysis of the loaded cell free medium (CFM), the pooled fractions from the 
chromatogram shown in panel A, and a protein marker (M). Note:  Elution 3 (E3) was not analyzed 
as it did not contain any protein and had high salt content. (C) Chromatogram when 60 mL of 
unadjusted spent LCM3 medium (pH 7) from the cultivation of JE5505 (pTrcKnPAC2902) was 
loaded to a 5 mL QFF column at flow rate of 4 mL/min. (D) SDS-PAGE analysis of pooled 
fractions from the chromatogram shown in panel C. Note: Elution 2 (E2) was not analyzed as it did 








Figure 3-4 –One percent agarose gel electrophoresis of chromatography fractions after separation of 
50mL of spent LCM3 medium adjusted to pH8 by a 5 mL QFF anion-exchange column at a flow 
rate of 1 mL/min. A 1 Kbp marker from Fermentas (M1), cell free medium (CFM), loading flow-












Table 3-2 – Quantification of the separation performance of PAC purification using the QFF 





































39 635 16.3 98% 3.2 
 
The observation that the majority of PAC was localized in the flow-through fraction without 
binding to the chromatographic medium was surprising considering its isoelectric point. It is 
believed to be caused by the competitive binding of various biomolecules, including contaminant 
proteins and oligopeptides. To verify this, different loading volumes of cell-free medium (i.e. 2.5, 
30, 60, and 300 mL) were applied to the chromatographic column under identical operating 
conditions (Figure. 3-5). No PAC breakthrough was detected when a small volume of 2.5 mL was 
loaded and PAC was entirely eluted in the fractions with a low ionic strength between 20-30 mM 
NaCl. On the other hand, when 30 mL of the cell-free medium (with 76% oligopeptide content 
based on the BCA assay) was loaded, highly purified PAC was collected in the flow-through 
fractions with most contaminant proteins being retained by the chromatographic column. However, 
oligopeptides cannot be completely eliminated from the product (with 32% oligopeptides content 
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based on the BCA assay). Increasing the loading volume to more than 60 mL will further release 
oligopeptides into the flow-through fractions (up to ~90% oligopeptides content based on the BCA 
assay). The results suggest a competitive binding scenario during the loading stage of the 
chromatographic operation, particularly under the condition of high loading volume. PAC appeared 
to be the major species in the cell-free medium with a low binding affinity (or surface charge) to the 
chromatographic medium and, as a result, increasing loading volume above 1 column volume could 
result in elution of the bound PAC by proceeding highly charged impurities. Thus, the loading 
volume will affect the purification performance of anion-exchange chromatography. While the 
presence of oligopeptides won’t affect PAC catalytic activity upon industrial applications, they can 













   
    
Figure 3-5 - Effect of loading volume on separation performance for 5mL QFF column operates at 
pH 7 and 4 mL/min. Location of major proteins of interest are indicated above the plot. UV 
absorbance is indicated with a solid line and conductivity is indicated with a dashed line. (A) 2.5 
mL (B) 30 mL (C) 60 mL (D) 300 mL. Note: a step-wise elution was used when 2.5 mL was loaded 




Chapter 4 – Simultaneous clarification of Escherichia coli culture and 
purification of extracellularly produced penicillin G acylase using 
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Downstream processing of bioprocesses for recombinant protein production includes several 
major preparative and purifying steps, i.e. clarification, capture, intermediate purification, polishing, 
and formulation [2, 3]. It often accounts for the most significant portion of protein manufacturing 
costs. Technological experience accumulated over the past few decades has highlighted the 
importance of more systematic and integrated approaches for optimal bioprocess development. In 
light of this, tackling technical issues in the upstream (i.e. strain construction) and/or midstream (i.e. 
cultivation) stages might become an effective solution to the reduction of the high costs associated 
with the downstream processing stage. However, practical demonstration of this well-perceived 
knowledge is still uncommon up to now because most recombinant proteins are produced 
intracellularly and, as a result, bioprocessing operations in the cultivation and downstream 
processing stages are rather independent. While strategies for extracellular production of 
recombinant proteins [11] have been proposed, downstream processing might remain tedious 
without excluding extensive preparative steps due to the composition incompatibility of the spent 
culture medium and chromatographic buffer.  
Among various techniques associated with downstream processing for recombinant protein 
production, membrane filtration and chromatography are commonly performed [2]. While 
traditional chromatographic columns are well characterized and widely used, they have many 
limitations, such as lengthy cleaning and packing steps, low diffusive binding of materials, low flow 
rate, high pressure drop, and long processing time [5]. Chromatographic membranes, on the other 
hand, offer numerous advantages over chromatographic columns, including high convective binding 
of materials, high flow rate, low pressure drop, short processing time, being disposable rendering 
regeneration and cleaning unnecessary, and being easy to scale up [4, 5, 30]. Moreover, 
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improvements in membrane chemistry have yielded better membrane products with various 
chromatographic functionalities, such as ion-exchange, affinity, and hydrophobic interaction, and 
high binding capacities comparable to resins [4, 5]. In particular, ion-exchange membrane 
chromatography is gaining popularity as a polishing step for the removal of virus particles and 
endotoxins upon the production of monoclonal antibodies [6]. Additionally, chromatographic 
membranes can be manufactured in a non-conventional format of cross-flow geometry, such as 
hollow-fiber, plate and frame or spiral wound devices, which was originally designed to reduce 
fouling during ultrafiltration [3-5]. These tangential flow devices give chromatographic membranes 
an extra dimension of applicability that has not been fully explored. 
Chromatography is usually the key step to increase the purity of recombinant protein during 
downstream processing. Prior to this step, extensive preparative steps, which may be as time-
consuming and costly as chromatographic operations, are required. For recombinant proteins 
produced intracellularly in E. coli, the preparative steps typically include centrifugation, cell 
disruption, filtration, precipitation, and desalting to formulate the lysate in a buffer compatible with 
the subsequent chromatographic operation (Figure 4-1). While the strategies for extracellular 
production of recombinant proteins have the major advantage of separating the recombinant protein 
product from most intracellular contaminant proteins, further purification of the secreted 
recombinant protein product will most likely require several of the above preparative steps for 
buffer exchange. Accordingly, simplification or even elimination of these preparative steps would 





Figure 4-1 - The proposed purification scheme investigated herein using tangential flow filtration 
(TFF) anion-exchange membrane chromatography (AEMC) to simultaneously clarify and purify 
extracellular PAC compared to an equivalent scheme using traditional AEC column 







In this study, we demonstrate a novel and effective bioprocess for extracellular production of 
recombinant protein in Escherichia coli and its immediate purification through the seamless 
integration of cultivation and downstream processing steps. The integrated system combined 
simultaneous operations of tangential flow filtration for culture clarification and anion-exchange 
membrane chromatography (TFF-AEMC) for PAC harvest/purification. Penicillin G acylase 
(PAC), an industrial enzyme for the production of β-lactam antibiotics [31], was used as a target 
protein for the demonstration since it is normally expressed as a periplasmic protein in E. coli. 
Extracellular production of recombinant PAC was achieved through the use of an outer-membrane 
mutant with a defective murein lipoprotein [10, 18, 26] as an expression host. The mutation resulted 
in the leakage of periplasmic proteins, including PAC, through the compromised outer-membrane 
into the extracellular medium with a minimal effect on cell growth. Compared to the traditional 
downstream processing for purification of intracellularly produced PAC using anion-exchange 
chromatography as the key purification step, the developed integrated system greatly reduced the 
length, complexity, and manufacturing costs of this bioprocess (Figure 4-1). The demonstration of 
TFF-AEMC for simultaneous culture clarification and recombinant protein purification significantly 
extends the benefits and applicability of the biochemical and genetic strategies for extracellular 
production of recombinant proteins.  
4.2 Materials and Methods 
4.2.1 Plasmids and strains 
The strain used for PAC expression in this study was E. coli JE5505 (Coli Genetic Stock Centre, 
Yale, USA) genotype (F
-
, Δ(gpt-proA)62, lacY1, tsx- 29, glnV44(AS), galK2(Oc), & λ-, Δlpp-254, 
pps-6,hisG4(Oc), xylA5, mtl-1, argE3(Oc), thi-1) [97]. Transformation was done by electroporation 
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using the E. coli Pulser (Bio-Rad, Hercules, CA). The plasmid pTrcKnPAC2902 containing the pac 
operon from E. coli ATCC11105 regulated by the trc promoter was previously constructed [96]. 
 
4.2.2 Cultivation methods 
The recombinant strain was stored at -80°C in a LB/glycerol stock. The cells were revived by 
plating on LB agar supplemented with kanamycin (50 μg/mL). A single colony was inoculated into 
a flask of 50 mL of LB broth (5 g/L yeast extract, 10 g/L tryptone, 0.5 g/L NaCl, and 50 μg/mL 
kanamycin) and incubated in a rotary shaker for 16 h at 30°C and 200 rpm. The 50 mL seed culture 
was inoculated into a bench-top bioreactor (Omni-Culture, VirTis, Gardiner, NY) containing 1 L 
working volume of LCM3 medium (5 g/L casamino acids, 2.5 g/L yeast extract, 20 mM 3-(N-
morpholino)propanesulfonic acid (MOPS) buffer, 2 mM NaCl, 2 mM MgSO4∙7H2O, 2 mM 
K2HPO4, 0.2 mM CaCl2 ∙2H2O, 1.5 mg/L FeSO4∙7H2O, 0.6 mg/L of MnSO4, 0.6 mg/L 
CuSO4∙5H2O, 0.6 mg/L ZnSO4∙7H2O) with 20 μL/L Antifoam 204 (Sigma, St. Louis, MO). The 
bioreactor was purged with filter-sterilized air at 2 vvm and agitated at 250 rpm. The pH was 
regulated at 7.0 ± 0.1 by the addition of 1 N NH4OH using a combination pH electrode (Mettler-
Toledo, Switzerland) a pH controller (PC310, Suntex, Taipei, Taiwan), and two MasterFlex 
peristaltic pumps (Cole-Palmer,Vernon Hills, IL, USA). The reactor was operated at 28°C for 
approximately 4 h until the cell density reached a density of 0.5 OD600 and protein expression was 
induced with 0.15 mM isopropyl-β-D-thiogalactopyranoside (IPTG) and the broth was harvested 12 
h post induction for purification.  
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4.2.3 Chromatography materials 
The strong anion-exchange (Q) membranes were provided by Natrix Separations Inc. (Burlington, 
ON, Canada). The typical mean dynamic binding capacity for BSA is 200 mg/mL of membrane 
volume at 10% break-through. Membranes were installed into a either a 25 or 47 mm stainless steel 
holder NX9100 series (Natrix Separations Inc., Burlington, Canada). One 25 mm membrane 
comprises 0.1 mL membrane volume while two 47 mm membranes comprise 0.75 mL of membrane 
volume. A 0.02 m
2
 cross-flow cassette comprises 5 mL of membrane. The loading/wash buffers 
were composed of either 25 mM Tris-HCl (pH 8) or 25 mM Bis-Tris-HCl (pH 7) where appropriate. 
The elution buffer consisted of the appropriate loading buffer containing 1 M NaCl. All buffers 
were prepared with 18 M deionized water and filtered with 0.45 μm polypropylene filters (VWR, 
Radnor, PA, USA).  
4.2.4 Dead end chromatography 
Dead end chromatography was performed using low pressure liquid chromatography system (Bio-
Logic LP, Biorad, Hercules, CA) with online UV absorbance at 280 nm and conductivity meters. 
These metrics were recorded using the accompanying software LP Logic (Biorad, Hercules, CA). 
Two 47 mm Q membrane cut discs in the stainless steel holder was attached upstream of the 
indicators and the inlet was downstream of a sample injection device. All runs were operated at a 
flow rate of 4 mL/min. The membrane was equilibrated for 15 min with the appropriate loading 
buffer. Culture broth was centrifuged at 6000 g for 10 min and adjusted to the appropriate pH then 
filtered using 0.22 μm polypropylene syringe filters (VWR, Radnor, PA, USA) prior to loading. 
Twenty milliliters of filtered cell free medium was loaded onto the membrane at a flow rate of 4 
mL/min. After loading, 60 mL of loading buffer was used to wash weakly bound protein from the 
membrane. After washing, a 60 mL linear salt elution gradient was applied to the membranes. Eight 
59 
 
millilitre fractions were collected with a fraction collector (BioLogic BioFrac, Biorad, Hercules, 
CA). Fractions were pooled into loading flow-through, washing flow-through, and two elution 
peaks. All fractions were assayed using the BCA and PAC enzymatic assay and analyzed for protein 
composition by SDS-PAGE. All dead-end experiments were performed in duplicate. 
 
4.2.5 Determination of Dynamic Binding Capacity 
Determination of the dynamic binding capacity was performed using the low pressure 
chromatography BioLogic system previously described. One 25 mm Q membrane cut disc in a 
stainless steel holder was equilibrated with 15 mL of loading buffer (25 mM Bis-Tris-HCl pH 7.0) 
at 1 mL/min prior to sample loading. One hundred milliliters of clarified spent medium with 
unadjusted pH (7.0 ± 0.1) was loaded to the membrane at 1 mL/min. Fractions were collected every 
1 min and analyzed for the relative purity of PAC in the flow-through by SDS-PAGE stained with 
silver nitrate and analyzed using Image J software (National Institute for Health). Effluent UV 
absorbance at 280 nm and conductivity were monitored as previously described. 
4.2.6 TFF-AEMC 
The cross-flow system was assembled using TangenX pressure gauges, TangenX cross flow 
apparatus (TangenX, Shrewsbury, MA, USA), Masterflex L/S 25 silicone tubing, Masterflex 7550-
60 computerized peristaltic pump (Cole-Palmer, Vernon Hills, IL, USA), 1 L pyrex reservoir bottle 
with bottom hose outlet, 1-L pyrex flask (Corning, Corning, NY, USA), and Explorer Pro EP2102 
balance (Parsippany, NJ, USA) as seen in Figure 4-2. A 0.02 m
2
 membrane cassette was hydrated 
by pumping 500 mL of 25 mM Bis-Tris-HCl pH 7 at a feed flow rate (FF) = 600 L/h∙m
2
 (LHM) and 
permeate flow rate (FP) = 60 LHM for 15 min. The membrane back-pressure was maintained at 5 
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psi for all subsequent steps using a pressure valve. After equilibration, the buffer from the reservoir 
and permeate was removed and discarded. One liter of either clarified (supernatant collected after 
centrifugation at 6000g for 6 min at 4°C) or non-clarified culture broth was added to the reservoir. 
The loading stage was conducted at FF = 600 LHM until 750 mL of permeate was collected. The 
remaining sample was removed from the reservoir and 500 mL of 25 mM Bis-Tris-HCl pH 7 was 
used to wash the membrane for 30 min at FF = 600 LHM. The wash buffer was removed and 250 
mL of 1 M NaCl in 25 mM Bis-Tris-HCl pH 7 was used to elute the contaminating proteins from 
the membrane for 30 min at FF = 600 LHM. The permeate and reservoir protein content was 
monitored by the BCA assay and PAC assay approximately every 30 min. The permeate flow rate 
was monitored during the loading stage using the balance. The UV absorbance at 280 nm was 






























A 25 fold reduction in oligopeptides was achieved by diafiltration using 3 kD nominal molecular 
weight cut-off (NMWCO) centrifugal devices and samples were resuspended in loading buffer to 
their original volume and analyzed using BCA assay, PAC assay and SDS-PAGE (Pall’s Corp., St. 
Louis, USA). Permeate was also subjected to 25 fold diafiltration using a 10 kD NMWCO cellulose 
membrane and a 200 mL stirred cell device (Millipore, Billerica, USA). Liquid was driven through 
the membrane by nitrogen that was used to pressurize the device to 25 psi.  
4.2.8 Enzymatic activity 
Penicillin G acylase was assayed at 37°C using penicillin G as a substrate. The amount of enzymatic 
reaction product of 6-aminopenicillanic acid (6-APA) was quantified using a colorimetric method 
developed previously [32]. All assays were conducted in duplicate. One unit was defined as the 
amount of enzyme that hydrolyzed 1.0 μmol penicillin G per minute at 37°C.  
4.2.9 Total protein determination 
The BCA assay for total protein concentration was performed using a kit (Pierce Biotechnology, 
Rockford, IL, USA) in a microplate assay format. Samples were all performed in duplicate and were 
appropriately diluted using the appropriate loading buffer to fall in the linear range of the kit; 20-
2000 μg/mL. The standard curve was performed in duplicate on each plate with BSA. Absorbance 
was measured at 562 nm with Thermo Labsystems Multiskan Ascent photometric plate reader 
(Thermo Scientific, Wilmington, USA). 
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4.2.10 SDS-PAGE  
Sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) was performed in a Mini-
PROTEAN II electrophoresis cell (Bio-Rad, Hercules, CA, USA) using a 12.5% polyacrylamide 
separating gel stacked by a 4% polyacrylamide stacking gel. The loading amount was 10 μL for 
chromatography fractions. Electrophoresis was conducted under a constant voltage of 200 V for 60 
min. Gels were stained using silver nitrate and dried. Dried gels were scanned using an HP laserjet 
scanner 3020.  
4.3 Results and Discussion 
4.3.1 Binding of PAC on anion-exchange membrane 
The rationale of the present study was to create an integrated downstream processing scheme 
with minimum preparative steps for direct harvest and purification of the extracellularly produced 
recombinant PAC using TFF-AEMC. To ensure the functional operation of anion-exchange 
membrane chromatography, the spent medium should have a sufficiently low conductivity for its 
direct processing without buffer exchange. Thus, medium composition and cultivation conditions 
were previously determined for effective extracellular production of recombinant PAC with 
minimum growth impairment. Using a bench-top bioreactor, JE5505 harboring pTrcKnPAC2902 
was cultivated in LCM3 media for extracellular production of PAC. The spent cell-free medium was 
collected at 12 h post-induction as protein expression had reached a plateau and extended cultivation 
would result in significant cell lysis which complicated downstream processing. At this time, the 
culture had a cell density of 2.8±0.3 OD600 with a specific extracellular PAC activity of 434±86 
U/L/OD600. Most importantly, the secretion efficiency was as high as 90% and the spent medium 
had a sufficiently low conductivity (5.9±0.8 mS/cm) to allow its direct loading for subsequent 
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anion-exchange chromatography. Recombinant PAC in the spent medium was purified based on a 
“negative” separation through which the majority of contaminant proteins bound to the anion-
exchanger and PAC was recovered in the flow-through fraction with a significantly increased purity.  
Theoretically, the operating conditions for ion-exchange chromatography should not differ 
remarkably between a column and a membrane. Nevertheless, binding of PAC onto the anion-
exchange membrane chromatography was characterized in this study with a dead-end membrane 
device to ensure its functional operation and optimize the purification performance. Using anion-
exchange membrane cut discs in a stainless steel holder with a low hold-up volume, the spent cell-
free medium at pH 7 containing recombinant PAC was loaded for chromatographic operation and 
the results are summarized in Figure 4-3. Various fractions were collected, pooled, and analyzed, 
including the loading flow-through, washing flow-through, and elution. These samples were also 
subjected to ultrafiltration (3 kD NMWCO) to remove residual oligopeptides in order to properly 
quantify the protein concentration. It was observed that recombinant PAC hardly bound to the 
anion-exchange membrane and the majority was collected in the flow-through fraction with 
significantly improved purity (Figure 4-3B). Two distinct peaks were shown upon the elution with 
salt and they were determined to primarily consist of contaminant proteins and RNA, respectively 
(Figure 4-3C). The results suggest that most contaminant proteins were removed through their 
binding onto the anion-exchange membrane and, as a result, PAC purity was significantly increased. 
The low level of RNA and plasmid DNA detected in the spent medium suggest minor cell lysis 
during the cultivation and the released nucleic acids were completely adsorbed by the anion-
exchange membrane and eluted at a high salt concentration (Figure 4-3C) without contaminating 
the purified PAC. PAC purification performance for anion-exchange membrane chromatography 
was found to be excellent under both pH 7 and pH 8 operating conditions (Table 4-1), implying a 
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precise pH control during the cultivation might not be critical. Because of the high costs associated 
with extensively purifying enzymes, industrial processes tend to use crude extracts or partially 
purified enzymes for catalysis. Hence, the purified PAC based on anion-exchange membrane 
chromatography in this study should be suitable for industrial applications even though it is not 









Figure 4-3 -Purification of extracellular PAC from 20 mL of cell free medium using Q membranes 
in dead-end flow format at pH 7 at 4 mL/min. [A] Chromatogram indicating the UV absorbance 
(solid line) and conductivity (dashed line). Fractions were pooled according to the 4 steps shown 
above the plot. [B] Pooled fractions from the separation in panel A were analyzed using SDS-
PAGE. Lanes contain protein markers (M), cell free medium (CFM), loading flow-through (L), 
washing flow-through (W), elution 1 (E1) and the ultrafiltrate of the loading flow-through (UF). 
PAC subunits are indicated with arrows. [C] One percent agarose gel electrophoresis of 
chromatography fractions. Lanes contain Fermentas 100 bp marker (M1), cell free medium (CFM), 







Table 4-1 - Performance of PAC purification by AEMC by direct loading of 20 mL of clarified 
culture supernatant to two 47 mm dead-end Q membranes operated at pH 7 and pH 8 with a flow-






















0.133 ± 0.007 0.69 ± 0.02 5.2 ± 0.3 - - 
Anion-
exchange 








0.03 ± 0.01 0.516 ± 0.008 17 ± 5 103%*  3.3 
Anion-
exchange  








0.03 ± 0.01 0.45 ± 0.02 15 ± 6 89%* 2.9 









In addition, the dynamic binding capacity of the anion-exchange membrane for binding of 
the contaminant proteins was evaluated by continuous loading of 100 mL spent cell-free medium 
through a 25 mm disc membrane and the results are summarized in Figure 4. No protein 
breakthrough occurred after loading the first 6 mL. SDS-PAGE analysis indicates that PAC was the 
first major protein to break through the membrane with a few minor contaminant proteins at the 
loading volume of 8 mL, suggesting that PAC might carry the least surface charge under these 
loading conditions. As expected, the break-through of the contaminant proteins increased with the 
loading volume and the PAC purity dropped slightly after a loading of 20 mL of the spent medium, 
resulting in approximately 85% PAC purity according to the densitometric analysis of the SDS-
PAGE gel. The purity decreased significantly when the loading volume was more than 35 mL. 
However, complete protein break-through was never achieved due to a serious membrane fouling 
which developed upon a loading of more than 50 mL of the spent medium. The results suggest that 





Figure 4-4 -Determination of dynamic binding capacity of Q membrane when 100 mL of clarified 
spent medium was loaded to one 25 mm cut disc operated at a volumetric flow rate of 1 mL/min and 
pH of 7.0. (A) Chromatogram of protein breakthrough. (B) SDS-PAGE analysis of corresponding 
protein breakthrough. PAC subunits, the protein marker molecular weights (M) and the time at 




4.3.2 Simultaneous culture clarification and PAC purification with TFF-AEMC 
Using the developed system of TFF-AEMC (Figure 4-2), one liter of the whole E. coli 
culture broth at pH 7 containing the extracellularly secreted recombinant PAC was processed and 
the results of which are summarized in Figure 4-5. The culture in the reservoir was circulated at a 
rate of 600 LHM for approximately 280 min with the back-pressure being maintained at 5 psi. The 
flow rate of the permeate was monitored to ensure no fouling of this system. The chromatogram 
associated with the TFF-AEMC operation is shown in Figure 4-5A. The total protein concentration 
of the permeate, in terms of the UV absorbance at 280nm, peaked upon the initial loading of the 
culture, then dropped slightly due to the binding of contaminant proteins onto the membrane, and 
remained relatively constant up to the washing step. The constant total protein concentration in the 
permeate leads to two observations. First, cell lysis was not aggravated during the TFF-AEMC 
processing. This is important, since further cell lysis would contaminate the extracellular medium 
and complicate PAC purification. Second, the binding of the extracellular contaminant proteins onto 
the membrane was effective without exceeding the chromatographic capacity of the membrane. 
Because PAC was unable to bind onto the anion-change membrane under the spent-medium 
conditions, the majority of it was collected in the permeate with a small amount of contaminant 
























Figure 4-5 -Purification of extracellular PAC using non-clarified cultivation broth and Q anion-
exchange cross-flow membranes. (A) Typical chromatogram of PAC purification using non-
clarified cultivation broth containing extracellular PAC. UV absorbance is indicated with a solid 
line, conductivity is indicated with a dashed line. (B) Monitoring for fouling and cell lysis during 
loading stage of cross-flow purification. Permeate flow rate in squares was used to monitor fouling, 
retentate total protein in circles was used to monitor the amount of lysis, and permeate total protein 
concentration in triangles was used to monitor the final product. (C) SDS-PAGE analyses of 
retentate protein content during cross-flow purification. Samples were collected from the reservoir 
from 0-280 min. The washing step retentate (W) and a protein marker (M) were also analyzed. (D) 
SDS-PAGE analysis of permeate samples taken during cross-flow operation. Samples were 
collected from the permeate effluent from 30-280 min. A protein marker (M), a sample of the 
washing step permeate (W), the elution step permeate (E) and the ultrafiltrate of the permeate (UF) 












Reduction in the volume of the retentate due to the draining of the permeate resulted in an 
increase in the cell density of the retentate. Out of the 1-L whole culture broth being processed, 
approximately 750 mL was collected as permeate containing purified PAC. The cell density in the 
retentate increased 4 fold. Because of the “negative” separation mode associated with PAC 
purification, the permeate containing the purified product was continuously drained from the 
processing stream. Hence, the system required a minimum operating volume (~ 100 mL in this 
study to cover the tubing volume and minimum working volume of the reservoir) for continuous 
operation. Such a minimum volume is not required for “positive” separations, for which the product 
to be purified binds onto the membrane and the processing is typically operated in a recycle mode 
though which the permeate is recycled back to the reservoir without being drained from the process 
stream [3, 58]. A major technical issue for the TFF-AEMC processing, particularly for that with a 
“negative” separation mode, is that the increasing cell density of the retentate tends to aggravate 
membrane fouling and consequently prevents product harvest/purification. The circulation rate of 
the whole culture broth has to be high enough to minimize the fouling without causing cell lysis. In 
this study, while the flow rate of the permeate began at a reasonably high level of approximately 38 
LHM, it quickly decreased to 10 LHM within the first 50 min of the processing and eventually 
reached a constant flow rate of approximately 6 LHM till the end (Figure 4-5B), suggesting 
membrane fouling was minimal.  
4.3.3 Analysis of protein compositions 
The total protein concentrations (analyzed by the BCA assay) for both cell-free retentate and 
permeate were maintained relatively constant at 700 g/mL and 570 g/mL, respectively, before 
200 min (Figure 4-5B), suggesting the processing resulted in minimum cell lysis during this time 
period. Note that oligopeptides were included when these two concentrations were analyzed with 
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the BCA assay and, after excluding oligopeptides based on the data in Table 4-2, the actual total 
protein concentrations for both cell-free retentate and permeate were estimated to be 140 g/mL and 
50 g/mL, respectively. The difference between these two concentrations, i.e. 90 g/mL, reflects 
the amount of contaminant proteins binding onto the membrane. Such binding behavior (internal 
fouling) was suspected to be the major cause of reduced permeate flow rate since a similar decrease 
in the permeate flow rate of the permeate was observed when clarified broth was applied under the 
same operating conditions a final constant flow rate of 6.0 LHM was reached after 80 min of 
processing. While the total protein concentration of the permeate was rather constant according to 
UV monitoring (Figure 4-4A), the BCA assay revealed low-level cell lysis towards the end of the 
processing, particularly after 200 min, when a slight increase in the total protein concentration for 
both the permeate and cell-free retentate were observed (Figure 4-4B). The protein composition of 
the cell-free retentate was also monitored by SDS-PAGE and low-level cell lysis could be detected 
by visualizing new bands in the late samples (i.e. 240-and 280-min) (Figure 4-4C). While no major 
difference in the protein composition of the cell-free retentate was observed, the volumetric PAC 
activity in this fraction increased over the time, i.e. from 1.08 U/mL at 0 min to 1.58 U/mL at 280 
min. Such concentration polarization is not unusual for ultrafiltration and is indicative of membrane 
fouling [3, 111] though the flow rate of the permeate was not fully stopped. If necessary, the fouling 
can be relieved by reversing the retentate flow direction or increasing the tangential flow rate to 
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Compared to the crude protein composition of the cell-free medium (i.e. the 0-min lane in 
Figure 5C), all permeate samples contained relatively pure PAC, for which both  and β subunits 
were clearly visible as the major bands (Figure 4-5D). Such a high PAC purity in the permeate was 
stably maintained throughout the entire period though there appears to be cell lysis towards the end 
of the processing. After approximately 750 mL of permeate was drained, the remaining retentate 
was collected and a wash buffer was used for brief circulation to remove any unbound proteins and 
cells from the system. All bound proteins on the anion-exchange membrane were eluted through a 
brief circulation of the loading buffer supplemented with 1 M NaCl. A large elution peak was 
visible on the chromatogram and the eluted proteins were collected from the permeate side. Both 
wash and elution fractions contained minimum PAC activities (less than 8% and 1% of the total 
PAC activity respectively) and were analyzed by SDS-PAGE (Figure 4-4D). The results suggest 
most contaminant proteins bound onto the anion-exchange membrane, resulting in a significant 
78 
 
increase of PAC purity in the permeate. Additionally, the purity of PAC in the permeate could be 
potentially affected by the conductivity of the spent medium, which determined the binding 
efficiency of contaminant proteins. 
4.3.4 PAC purification performance 
The performance for the one-step purification of PAC by TFF-AEMC is summarized in Table 
4-2. A minor technical issue associated with the purification of PAC in this study (i.e. a “negative” 
separation mode) was the presence of oligopeptides in the spent medium. Because oligopeptides 
hardly bound onto the anion-exchange membrane, they coexisted with purified PAC in the 
permeate. Such a technical issue would not exist for a “positive” separation mode, for which 
oligopeptides could be easily separated from the target protein binding onto the ion-exchange 
membrane. While the oligopeptides will not affect the catalytic activity of PAC upon industrial 
applications, if necessary, they can be easily removed by ultrafiltration during the concentration step 
given that the permeate was already pre-filtered by microfiltration upon the TFF-AEMC processing. 
The specific PAC activity for the crude cell-free spent medium was already as high as 7.33 U/mg 
protein (excluding oligopeptides). With the TFF-AEMC processing, it reached an extremely high 
level of 19.1 U/mg protein (excluding oligopeptides), resulting in a 3.4 fold purification. Note that 
the specific activity of PAC from SIGMA-ALDRICH (catalog no. 76427) was only 5-10 U/mg 
protein. In addition to the high purification fold, the recovery of PAC activity for the TFF-AEMC 
processing was as high as 96%. This means 72% of PAC in the 1-L cell-free medium was harvested 
and purified in the 750-mL permeate. This overall recovery was limited by the volume of permeate 
that could be separated/drained from the whole culture during the TFF-AEMC processing. 
Regardless, 72% is still considered an excellent yield and is often higher than the yields associated 
with the traditional multi-step processes for purifying intracellular PAC. Also importantly, the 
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overall batch cycle time involved in the developed bioprocess, including both cultivation and TFF-





Chapter 5 - Conclusions and Recommendations 
5.1 Conclusions 
The integrated bioprocess developed in this work is a highly simplified, inexpensive, and 
easily implemented system for recombinant protein production and purification. The outer-
membrane mutant strain of JE5505 was demonstrated to be an effective cell factory for the 
extracellular production of periplasmic PAC under proper culture conditions. While growth 
impairment was detected under certain low osmolarity conditions, the expression host strain 
exhibited a high level of pac expression with excellent secretion efficiency. The extracellularly 
secreted PAC was subsequently harvested and purified by “negative” separation upon direct loading 
of the spent medium to TFF-AEMC. This one-step downstream purification simultaneously clarified 
and purified recombinant PAC based on the dual nature of the anion-exchange membrane as a filter 
and a chromatographic medium. The decreased number of steps for downstream processing and 
excellent purification performance could represent a significant cost saving for manufacturing of 
recombinant PAC. Due to the non-selective nature of the secretion system (i.e. any periplasmic 
proteins can be potentially secreted) and the versatility of ion-exchange chromatography, the 
developed strategy could be easily implemented for the production of many recombinant proteins 
making the developed bioprocess and its associated equipment extremely versatile an advantage 
rarely encountered in protein manufacturing. Overall, a high purity of PAC was achieved based on 
this simple one-step purification. The current study has demonstrated that perceptive design in the 
upstream (i.e. strain construction) and midstream (i.e. cultivation) stages can greatly enhance the 
performance of the downstream processing, particularly the often overlooked preparatory steps. 
While such an integrated approach potentially represents an effective strategy for novel bioprocess 
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design, it also provides a major challenge in identification of key factors and/or bioprocess variables 
for systematic optimization of the overall bioprocess. For example, with respect to the currently 
developed host/vector system effective in the extracellular production of PAC, further optimization 
of the culture medium to sustain both high-cell-density cultivation and high-level pac expression 
without losing its compatibility for downstream processing remains a challenge.  
5.2 Recommendations 
A highly simplified bioprocess for the production and purification of extracellular proteins in E. coli 
has been successfully demonstrated. Several factors were determined to have an effect on separation 
performance and secretion efficiency; however, further study is required to determine the acceptable 
operating range of these parameters. Consequently, the following investigations are recommended: 
Upstream Development: 
1. Low cell density was found to be a significant obstacle in the endeavor to increase 
productivity of the developed bioprocess. While this problem may be partially tackled 
through biochemical optimization of the midstream cultivation, the results upon the 
cultivation of HB101 harboring pTrcKnPAC2902 suggest additional upstream development 
may be a more effective solution. Under identical conditions, HB101 (pTrcKnPAC2902) 
out-performed JE5505 (pTrcKnPAC2902) as this culture reached a higher cell density and 
all PAC expressed was found to be in its soluble active form. Taking this into consideration, 
low cell density during the cultivation of JE5505 (pTrcKnPAC2902) may simply be a result 
of growth arrest due to the physiological stress of inclusion body formation, or may be due 
to differences in host genetic background. As it is known that some E. coli strains are 
capable of higher cell densities, knockout of the lpp gene in HB101 could allow HB101 to 
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acquire the “leaky” phenotype while maintaining the high level expression of soluble PAC 
and high cell density and should be explored [43].  
2. Inclusion body formation during cultivation of JE5505 harboring pTrcKnPAC2902 was 
suspected to be a major impediment in the efficiency of PAC expression and extended 
cultivation lead to cell lysis resulting in low cell density. Inclusion body formation in this 
case may be a result of the dilution of periplasmic folding modulators and disulfide bond 
forming proteins upon leakage into the extracellular medium, consequently, coexpression of 
folding chaperones may alleviate inclusion body formation. This strategy has previously 
been demonstrated to successfully increase soluble PAC productivity in the periplasm in this 
lab and successful resolution of this problem could help our understanding of the mechanism 
of inclusion body formation in E. coli and  requires further study [112, 113]. 
3. Finally, inclusion body formation may be due solely to the nature of the posttranslational 
modifications required for formation of functional PAC; therefore, this issue may not exist 
upon the expression of other recombinant proteins with straightforward posttranslational 
processing. This may be investigated by examining this host under the developed conditions 
upon the expression of other recombinant proteins.  
Midstream Development: 
1. Cultivation conditions for the production of PAC was only briefly explored in this work, and 
as a result, both cell density and PAC productivity could greatly benefit from a full 
optimization of the culture conditions, particularly medium composition and induction 
conditions.  
2. A significant challenge to the successful integration of the production and purification of 
PAC was the necessity to maintain low conductivity and high cell densities in a batch 
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bioreactor. Additionally, due to the acidification of the medium during culture growth, pH 
control significantly contributed to the conductivity of the spent medium. Thus, batch and 
fed-batch cultivation are poor techniques for meeting these requirements and thus chemostat 
cultivation should be explored. Conductivity of the spent medium would easily be 
maintained in a chemostat due to the continuous dilution of the culture medium by the feed. 
Additionally, this may provide another method of addressing the low cell density issue as 
higher cell densities are more readily achieved during chemostat operations.   
Downstream Development: 
1. Several factors affecting the separation performance of PAC by TFF-AEMC were 
indentified, primarily the conductivity and pH of the spent medium. However, many factors 
are known to affect the performance of membranes in TFF such as transmembrane pressure, 
flow-rate, flow direction, and thus a more throughout investigation of both the possible 
operating range of the feed and the TFF-AEMC should be performed.  
2. Additionally, a study of the effects of flow rate and cell density on fouling and cell lysis 
should be undertaken to determine any correlation between these factors and thus the 
possible operational limitations of this particular bioprocess.  
3. One major disadvantage of the developed bioprocess was the need to remove peptides 
remaining in the loading flow-through and concentrate the product using ultrafiltration. 
Ultrafiltration is an expensive time consuming technique. This particular technical issue only 
pertains to flow-through applications and not bind-elute strategies, thus, a bind-elute strategy 
could be far more productive than a flow-through operation and can be demonstrated by 
applying this bioprocess to another more highly charged target protein and thus concurrently 
prove the versatility of the developed system.   
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4. Finally, while this process was found to be exceedingly simple and fast, processing time 
could be further decreased by the direct coupling of chemostat effluent to TFF-AEMC 
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